Obesity is a major risk factor for developing gallstone disease (GSD). Previous studies have
shown that obesity is associated with an elevated Firmicutes/Bacteroidetes ratio in the gut …

Berberine (BBR), an isoquinoline alkaloid, has been found in many plants, such as Coptis
chinensis Franch and Phellodendron chinense Schneid. Although BBR has a wide spectrum …

This study investigated the effects of dietary supplementation with Bacillus subtilis (B.
subtilis) or Bacillus licheniformis (B. licheniformis) on growth performance, immunity …

Abstract Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite
trimethylamine (TMA), has been identified to be an independent risk factor for promoting …

Obesity has become a major risk factor for the development of chronic diseases such as
insulin resistance, type 2 diabetes mellitus, and cardiovascular disease. Moreover, obesity …

Cardiovascular diseases (CVD) are a group of disorders of the heart and blood vessels and
remain the leading cause of morbidity and mortality worldwide. Over the past decades …

Metabolic diseases such as obesity, type 2 diabetes mellitus, and hyperlipidemia are
associated with the dysfunction of gut microbiota. Traditional Chinese medicines (TCMs) …

In the last few decades, traditional natural products have been the center of attention for the
scientific community and exploration of their therapeutic abilities is proceeding perpetually …

Background: Insulin secretory agents are commonly used to treat type 2 diabetes. However,
traditional insulin secretory agents such as sulfonylureas and glinides have side effects of …

Introduction Obesity is a complex, multifactorial disease caused by various factors. Recently,
the role of the gut microbiota in the development of obesity and its complications has …